Last10K.com

Acrongenomics Inc (AGNM) SEC Filing 10-Q Quarterly report for the period ending Thursday, March 31, 2011

Acrongenomics Inc

CIK: 1104502 Ticker: AGNM

View differences made from one quarter to another to evaluate Acrongenomics Inc's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-Q Quarterly Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Acrongenomics Inc.

Continue

Assess how Acrongenomics Inc's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Acrongenomics Inc's Definitive Proxy Statement (Form DEF 14A) filed after their 2012 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools
Ticker: AGNM
CIK: 1104502
Form Type: 10-Q Quarterly Report
Accession Number: 0001062993-12-002019
Submitted to the SEC: Mon Jun 04 2012 3:16:25 PM EST
Accepted by the SEC: Mon Jun 04 2012
Period: Thursday, March 31, 2011
Industry: Surgical And Medical Instruments And Apparatus

External Resources:
Stock Quote
Social Media

Bookmark the Permalink:
https://last10k.com/sec-filings/agnm/0001062993-12-002019.htm